Bowden S - Search Results

1

Rescue therapy for drug resistant hepatitis B: another argument for combination chemotherapy?

Shaw T, Bowden S, Locarnini S. Shaw T, et al. Among authors: bowden s. Gastroenterology. 2004 Jan;126(1):343-7. doi: 10.1053/j.gastro.2003.11.022. Gastroenterology. 2004. PMID: 14699512 Review. No abstract available.

2

Chemotherapy for hepatitis B: new treatment options necessitate reappraisal of traditional endpoints.

Shaw T, Bowden S, Locarnini S. Shaw T, et al. Among authors: bowden s. Gastroenterology. 2002 Dec;123(6):2135-40. doi: 10.1053/gast.2002.37288. Gastroenterology. 2002. PMID: 12454868 Review. No abstract available.

3

Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.

Sievert W, Pianko S, Warner S, Bowden S, Simpson I, Bowden D, Locarnini S. Sievert W, et al. Among authors: bowden s, bowden d. Am J Gastroenterol. 2002 Apr;97(4):982-7. doi: 10.1111/j.1572-0241.2002.05550.x. Am J Gastroenterol. 2002. PMID: 12003436

4

Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.

Chen RY, Bowden S, Desmond PV, Dean J, Locarnini SA. Chen RY, et al. Among authors: bowden s. J Gastroenterol Hepatol. 2003 Jun;18(6):630-7. doi: 10.1046/j.1440-1746.2003.03019.x. J Gastroenterol Hepatol. 2003. PMID: 12753143

5

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, Trepo C, Marcellin P, Goodman Z, Delaney WE 4th, Xiong S, Brosgart CL, Chen SS, Gibbs CS, Zoulim F. Werle-Lapostolle B, et al. Among authors: bowden s. Gastroenterology. 2004 Jun;126(7):1750-8. doi: 10.1053/j.gastro.2004.03.018. Gastroenterology. 2004. PMID: 15188170

6

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy.

Sung JJ, Wong ML, Bowden S, Liew CT, Hui AY, Wong VW, Leung NW, Locarnini S, Chan HL. Sung JJ, et al. Among authors: bowden s. Gastroenterology. 2005 Jun;128(7):1890-7. doi: 10.1053/j.gastro.2005.03.009. Gastroenterology. 2005. PMID: 15940624 Clinical Trial.

7

Hepatitis B: the case for combination therapy.

Bowden S, Shaw T. Bowden S, et al. Curr Opin Investig Drugs. 2009 Aug;10(8):795-803. Curr Opin Investig Drugs. 2009. PMID: 19649924 Review.

8

Drug resistance in antiviral therapy.

Locarnini S, Bowden S. Locarnini S, et al. Among authors: bowden s. Clin Liver Dis. 2010 Aug;14(3):439-59. doi: 10.1016/j.cld.2010.05.004. Clin Liver Dis. 2010. PMID: 20638024 Review.

9

Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.

Bowden S, Locarnini S, Chang TT, Chao YC, Han KH, Gish RG, de Man RA, Yu M, Llamoso C, Tang H. Bowden S, et al. World J Gastroenterol. 2015 Apr 21;21(15):4644-51. doi: 10.3748/wjg.v21.i15.4644. World J Gastroenterol. 2015. PMID: 25914474 Free PMC article. Clinical Trial.

10

TT virus: an agent of transfusion-associated hepatitis or yellow herring?

Bowden S, Locarnini S. Bowden S, et al. J Gastroenterol Hepatol. 1999 Apr;14(4):299-300. doi: 10.1046/j.1440-1746.1999.01852.x. J Gastroenterol Hepatol. 1999. PMID: 10207775 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters